PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
July 17, 2019Journal of the American Heart Association85 citationsOpen Access

Clinical Features and Outcomes of Patients With Malignancy and Takotsubo Syndrome: Observations From the International Takotsubo Registry

View Full Paper
VCVictoria L. CammannASAnnahita SarconKDKatharina J. Ding

Structured PICO

Does the presence of malignancy affect short- and long-term mortality in patients with Takotsubo syndrome?

P
Population
1604 patients with Takotsubo syndrome (TTS) enrolled from the International Takotsubo Registry
I
Intervention
Presence of malignancy
C
Comparator
Absence of malignancy
O
Outcome
Short- and long-term mortalityhard clinical

Malignancy is present in approximately 16.6% of patients with Takotsubo syndrome and serves as an independent predictor of increased long-term mortality.

Abstract

Background Clinical characteristics and outcomes of takotsubo syndrome (TTS) patients with malignancy have not been fully elucidated. This study sought to explore differences in clinical characteristics and to investigate short- and long-term outcomes in TTS patients with or without malignancy. Methods and Results TTS patients were enrolled from the International Takotsubo Registry. The TTS cohort was divided into patients with and without malignancy to investigate differences in clinical characteristics and to assess short- and long-term mortality. A subanalysis was performed comparing long-term mortality between a subset of TTS patients with or without malignancy and acute coronary syndrome (ACS) patients with or without malignancy. Malignancy was observed in 16.6% of 1604 TTS patients. Patients with malignancy were older and more likely to have physical triggers, but less likely to have emotional triggers compared with those without malignancy. Long-term mortality was higher in patients with malignancy (P<0.001), while short-term outcome was comparable (P=0.17). In a subanalysis, long-term mortality was comparable between TTS patients with malignancies and ACS patients with malignancies (P=0.13). Malignancy emerged as an independent predictor of long-term mortality. Conclusions A substantial number of TTS patients show an association with malignancy. History of malignancy might increase the risk for TTS, and therefore, appropriate screening for malignancy should be considered in these patients. Clinical Trial Registration URL: http://www.clinicaltrial.gov. Unique identifier: NCT01947621.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Cammann et al. (2019) studied this question.

synapsesocial.com/papers/6a75801e1078cf7de2b22510https://doi.org/10.1161/jaha.118.010881
Ask AI
Helpful
Bookmark
Share
View Full Paper